These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1660142)

  • 41. Activation of HIV-specific ribozyme activity by self-cleavage.
    Ventura M; Wang P; Ragot T; Perricaudet M; Saragosti S
    Nucleic Acids Res; 1993 Jul; 21(14):3249-55. PubMed ID: 8341599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. U1 small nuclear RNA chimeric ribozymes with substrate specificity for the Rev pre-mRNA of human immunodeficiency virus.
    Michienzi A; Prislei S; Bozzoni I
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7219-24. PubMed ID: 8692972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro analysis of a hammerhead ribozyme targeted to infectious bronchitis virus nucleocapsid mRNA.
    Callison SA; Hilt DA; Jackwood MW
    Avian Dis; 2005 Mar; 49(1):159-63. PubMed ID: 15839432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction of a novel artificial-ribozyme-releasing plasmid.
    Taira K; Oda M; Shinshi H; Maeda H; Furukawa K
    Protein Eng; 1990 Aug; 3(8):733-7. PubMed ID: 2217147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine.
    Scanlon KJ; Kashani-Sabet M; Sowers LC
    Cancer Commun; 1989; 1(4):269-75. PubMed ID: 2534792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a good c-myc antisense oligodeoxynucleotide target site and the inactivity at this site of novel NCH triplet--targeting ribozymes.
    Giles RV; Spiller DG; Clark RE; Tidd DM
    Nucleosides Nucleotides; 1999 Sep; 18(9):1935-44. PubMed ID: 10549146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
    Kisich KO; Freedland SJ; Erickson KL
    Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines.
    Bonovich M; Olive M; Reed E; O'Connell B; Vinson C
    Cancer Gene Ther; 2002 Jan; 9(1):62-70. PubMed ID: 11916245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effective ribozyme delivery in plant cells.
    Perriman R; Bruening G; Dennis ES; Peacock WJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6175-9. PubMed ID: 7597097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Preparation and characterization of ribozyme for tissue inhibitor of metalloproteinases-1 mRNA ribozymes in vitro].
    Wang ZM; Wu JM; Lin ZH; Jiang H; Song YH; Jin YX
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):387-90. PubMed ID: 12673396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
    Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M
    Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation and characterization of hammerhead ribozymes targeting rodent metallothionein-I and -II ribonucleic acid.
    Lee KF; Lau KM; Ho SM
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):294-301. PubMed ID: 10620487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ribozyme cleaves rex/tax mRNA and inhibits bovine leukemia virus expression.
    Cantor GH; McElwain TF; Birkebak TA; Palmer GH
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):10932-6. PubMed ID: 7504287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme.
    Luzi E; Papucci L; Schiavone N; Donnini M; Lapucci A; Tempestini A; Witort E; Nicolin A; Capaccioli S
    Cancer Gene Ther; 2003 Mar; 10(3):201-8. PubMed ID: 12637941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific gene suppression by engineered ribozymes in monkey cells.
    Cameron FH; Jennings PA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9139-43. PubMed ID: 2556702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stable expression of anti-HPV 16 E7-ribozyme in CV-1 cell lines.
    Huang Y; Kong Y; Wang Y; Qi G; Lu C
    Chin J Biotechnol; 1996; 12(4):215-20. PubMed ID: 9187492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.